Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 1, 2024
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
[ Fri, Mar 01st 2024
] - WOPRAI
Oren Livnat Maintained (VRCA) at Strong Buy with Increased Target to $13 on, Mar 1st, 2024
Oren Livnat of HC Wainwright & Co., Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Increased Target from $12 to $13 on, Mar 1st, 2024.
Oren has made no other calls on VRCA in the last 4 months.
There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Glen Santangelo of "Jefferies" Reiterated at Strong Buy and Held Target at $10 on, Friday, December 15th, 2023
